DK0497929T3 - Præparat til stabilisering af blodplasma under pasteurisering - Google Patents

Præparat til stabilisering af blodplasma under pasteurisering

Info

Publication number
DK0497929T3
DK0497929T3 DK91912152.5T DK91912152T DK0497929T3 DK 0497929 T3 DK0497929 T3 DK 0497929T3 DK 91912152 T DK91912152 T DK 91912152T DK 0497929 T3 DK0497929 T3 DK 0497929T3
Authority
DK
Denmark
Prior art keywords
blood plasma
preparation
stabilizing blood
plasma during
during pasteurization
Prior art date
Application number
DK91912152.5T
Other languages
English (en)
Inventor
Myriana Burnouf
Thierry Burnouf
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Application granted granted Critical
Publication of DK0497929T3 publication Critical patent/DK0497929T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21027—Coagulation factor XIa (3.4.21.27)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91912152.5T 1990-07-03 1991-06-20 Præparat til stabilisering af blodplasma under pasteurisering DK0497929T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9008375A FR2664165B1 (fr) 1990-07-03 1990-07-03 Composition pour stabiliser le plasma sanguin en cours de pasteurisation.

Publications (1)

Publication Number Publication Date
DK0497929T3 true DK0497929T3 (da) 1996-07-22

Family

ID=9398269

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91912152.5T DK0497929T3 (da) 1990-07-03 1991-06-20 Præparat til stabilisering af blodplasma under pasteurisering

Country Status (22)

Country Link
EP (1) EP0497929B1 (da)
JP (1) JP3132828B2 (da)
AT (1) ATE135238T1 (da)
AU (1) AU8062991A (da)
CA (1) CA2065284A1 (da)
CZ (1) CZ281431B6 (da)
DE (1) DE69117920T2 (da)
DK (1) DK0497929T3 (da)
ES (1) ES2084821T3 (da)
FI (1) FI96918C (da)
FR (1) FR2664165B1 (da)
GR (1) GR3020048T3 (da)
HU (1) HU208404B (da)
LT (1) LT3419B (da)
LV (1) LV10384B (da)
NO (1) NO179127C (da)
PL (1) PL166579B1 (da)
PT (1) PT98190B (da)
RU (1) RU2045902C1 (da)
SK (1) SK279031B6 (da)
WO (1) WO1992000767A1 (da)
ZA (1) ZA914848B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687317B1 (fr) 1992-02-13 1995-06-23 Aetsrn Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.
DE4240103A1 (de) * 1992-05-26 1993-12-02 Behringwerke Ag Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
DE19508192A1 (de) 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
WO2017155678A1 (en) * 2016-03-10 2017-09-14 Kindheart, Inc Fake blood for use in simulated surgical procedures

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
DE3176491D1 (en) 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK18288D0 (da) * 1988-01-15 1988-01-15 Nordisk Gentofte Fremgangsmaade til pasteurisering af vandige oploesninger af faktor viii

Also Published As

Publication number Publication date
AU8062991A (en) 1992-02-04
PT98190A (pt) 1992-05-29
LV10384A (lv) 1995-02-20
GR3020048T3 (en) 1996-08-31
EP0497929B1 (fr) 1996-03-13
FI920934A0 (fi) 1992-03-02
JP3132828B2 (ja) 2001-02-05
PL294037A1 (en) 1993-01-11
FR2664165B1 (fr) 1992-10-16
ZA914848B (en) 1992-04-29
NO920791L (no) 1992-02-28
FR2664165A1 (fr) 1992-01-10
NO179127C (no) 1996-08-14
RU2045902C1 (ru) 1995-10-20
DE69117920T2 (de) 1996-10-02
NO920791D0 (no) 1992-02-28
ES2084821T3 (es) 1996-05-16
HU9200701D0 (en) 1992-05-28
LV10384B (en) 1995-04-20
DE69117920D1 (de) 1996-04-18
HUT60148A (en) 1992-08-28
HU208404B (en) 1993-10-28
LT3419B (en) 1995-09-25
WO1992000767A1 (fr) 1992-01-23
ATE135238T1 (de) 1996-03-15
JPH05501417A (ja) 1993-03-18
SK279031B6 (sk) 1998-05-06
NO179127B (no) 1996-05-06
LTIP264A (en) 1994-10-25
FI96918B (fi) 1996-06-14
PT98190B (pt) 1998-12-31
CS57992A3 (en) 1992-08-12
FI96918C (fi) 1996-09-25
CZ281431B6 (cs) 1996-09-11
EP0497929A1 (fr) 1992-08-12
CA2065284A1 (fr) 1992-01-04
PL166579B1 (pl) 1995-06-30

Similar Documents

Publication Publication Date Title
IT8023749A0 (it) Protesi anulare regolabile per chirurgia cardiaca.
ATE269290T1 (de) Benzoylderivate
ATE1241T1 (de) Verfahren zur herstellung von 4,5-perfluor-1,3-dioxolanen.
DK0556096T3 (da) Præparat til stabilisering af blodplasma under pasteurisering samt pasteuriseret plasmaopløsning til terapeutisk brug
DK406184D0 (da) Fremgangsmaade til pasteurisering af humanplasma
DK0497929T3 (da) Præparat til stabilisering af blodplasma under pasteurisering
DK418986A (da) Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
DK495786D0 (da) Fremgangsmaade til fremstilling af halogen-magnesium-alanat og alanatets anvendelse
DK374887A (da) 2-acyloxypropropylamin-derivater, deres fremstilling og anvendelse
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
DE69004244T2 (de) Verfahren zur Herstellung von hohen Anteilen des trans,trans-Isomeren enthaltenden 4,4'-Diisocyanatodicyclohexylmethan.
DE3173084D1 (en) Use of a substance obtained from blood serum for the stabilization of prostaglandins
DE3774715D1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
DK474984A (da) N-(4-acetylaminophenacyl)-aminderivater, deres terapeutiske anvendelse og deres fremstilling
DK300083A (da) Fremgangsmaade til fremstilling af et nonapeptid med immunstimulerende virkning
ITAP930004U1 (it) Sistema di correzione del procurvato e del recurvato per allungatori di arti
DK581086A (da) Fremgangsmaade til fremstilling af alkyltrifluoracetater
IT7926193A0 (it) Procedimento per la preparazione di un attivatore della polimerizzazione anionica del 2-pirrolidone.